stockchase picture

Compiling comments that experts make about stocks while on public TV.

2012-07-09

Opinion for Abbott Labs (ABT-N)

Signal Price Bias Subject Owned
$65.610 CAUTIOUS NORTH AMERICAN - LARGE Yes

Will be splitting the company into 2 parts, pharma side and medical devices. Purchased a generic company out of India last year and India will be providing health care to the general population but will only pay for generic drugs . Currently within a couple of dollars of her target price so she might shave some of her holdings.

Christine Poole
Managing Director, GlobeInvest Capital Management

No Comments.


You must be logged in to comment.